Rotavirus Vaccines Completed Phase 3 Trials for Rotavirus Vaccine (DB10276)

Also known as: Rotavirus Vaccine

IndicationStatusPhase
DBCOND0033911 (Rotavirus Vaccines)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02914184Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 WeeksPrevention
NCT00480324Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese InfantsPrevention
NCT00241644Vaccine Efficacy Against Rotavirus Diarrhea; Vaccine Given With Routine Childhood Vaccinations in Healthy African InfantsPrevention
NCT00757770Assessment of Clinical Consistency of Three Production Lots of GSK Biologicals' HRV VaccinePrevention
NCT02193061Randomized, Controlled Single-blind Clinical Study to Assess Vaccine Interchangeability Between RV5 and RV1 Using Seven Combined Anti-rotavirus Prevention ProgramsPrevention